Lv2
180 积分 2026-01-19 加入
Second Attempt of TKI Discontinuation with Dasatinib for Treatment-Free Remission after Failing First Attempt with Imatinib: Treatment-Free Remission Accomplished By Dasatinib (TRAD) Trial
2个月前
已采纳
Factors Influencing Efficacy of CD19-CAR-T Cells in Children and Adults with Relapsed/Refractory B-Cell Lymphoblastic Leukemia
2个月前
已采纳
Management of Primary Gastrointestinal Non-Hodgkin Lymphoma with Lenalidomide
2个月前
已采纳
A Phase 2 Open-Label Study of Danicopan (ACH-0144471) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have an Inadequate Response to Eculizumab Monotherapy
2个月前
已采纳
Alpine: Phase 3 Trial of Zanubrutinib (BGB-3111) Vs Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
2个月前
已采纳
The Evaluation of Residual Disease By Digital PCR, and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after for Stopping Imatinib First-Line in Chronic Phase CML Patients: Results of the STIM2 Study
2个月前
已采纳
Marcks Inhibition By a Peptide Inhibitor, MPS, Cooperates with Bortezomib to Effectively Eliminate Drug Resistance in Multiple Myeloma
2个月前
已采纳
Dual Targeting of PI3Kdelta and BRD4 Sensitizes Acute Lymphoblastic Leukemia to Chemotherapy
2个月前
已采纳
The Change Regulation of Joint Structure and Function in Children with Severe Hemophilia a Receiving Low and Intermediate-Dose for Prophylaxis
2个月前
已采纳
Chronic Myeloid Leukemia Incidence Based Estimates of Hematopoietic Stem Cell Numbers per Person
2个月前
已采纳
皖公网安备34019202002308
